Asthma Clinical Trials in Pittsburgh, Pennsylvania

6 studies are recruiting for asthma in Pittsburgh, Pennsylvania right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. A Study Evaluating Disease Characteristics and Outcomes in Participants With Asthma in Routine Clinical Practice

   The main aim of the study to describe the characteristics of participants with asthma across the spectrum of disease severity, including sociodemographic and clinical characteristics, treatment and disease burden, biomarkers, and both disease-specific and generic health-related quality of life. The…

   Stage

   Not phased

   Ages

   6 and older

   Site

   Allergy and Clinical Immunology Associates - Site Number: 840127, Pittsburgh, Pennsylvania

   Locations

   62 in total

   Run by

   Sanofi

   See if you can join NCT07556159 on ClinicalTrials.gov

2. A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma

   The primary objective of the trial is to evaluate the efficacy of fluticasone propionate/albuterol sulfate multidose dry powder inhaler with electronic module (Fp/ABS eMDPI). Secondary objectives are: * To evaluate the efficacy of Fp/ABS eMDPI administered four times daily * To evaluate the safety …

   Stage

   Phase 3

   Ages

   12 and older

   Site

   Teva Investigational Site 12114, Pittsburgh, Pennsylvania

   Locations

   189 in total

   Run by

   Teva Branded Pharmaceutical Products R&D LLC

   See if you can join NCT06664619 on ClinicalTrials.gov

3. A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma

   The purpose of this study is to assess the safety and efficacy of brenipatide at different dose levels compared with placebo in participants with moderate-to-severe asthma. Study participation will last approximately 65 weeks, including screening, treatment, and follow-up periods.

   Stage

   Phase 2

   Ages

   18 to 75

   Site

   University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania

   Locations

   121 in total

   Run by

   Eli Lilly and Company

   See if you can join NCT07219173 on ClinicalTrials.gov

4. Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma

   The purpose of this study is to compare the effect of budesonide/albuterol metered-dose inhaler (BDA MDI) with albuterol sulfate metered-dose inhaler (AS MDI), both administered as needed, on the annualized rate of severe asthma exacerbations in adolescents with a documented clinical diagnosis of a…

   Stage

   Phase 3

   Ages

   12 to 17

   Site

   Research Site, Pittsburgh, Pennsylvania

   Locations

   150 in total

   Run by

   AstraZeneca

   See if you can join NCT06307665 on ClinicalTrials.gov

5. Measuring the Effect of Dupilumab Treatment on Mucociliary Clearance (MCC) in Subjects With Moderate to Severe Asthma

   Single center, randomized, placebo- controlled study to assess change in mucociliary clearance of moderate to severe asthma patients after treatment with dupilumab or placebo.

   Stage

   Phase 4

   Ages

   18 and older

   Site

   The University of Pittsburgh Asthma Institute at UPMC, Pittsburgh, Pennsylvania

   Run by

   Sally E. Wenzel MD

   See if you can join NCT04743791 on ClinicalTrials.gov

6. Acoustic Waveform Respiratory Evaluation

   The study will evaluate the feasibility of using smartphone speakers and microphones to evaluate the caliber of the airways, detect airway obstruction, aid in airway disease diagnosis, and identify disease exacerbations.

   Stage

   Not phased

   Ages

   8 to 70

   Site

   University of Pittsburgh, Pittsburgh, Pennsylvania

   Locations

   2 in total

   Run by

   Indiana University

   See if you can join NCT06512064 on ClinicalTrials.gov